HUP0401967A2 - Nikotinsav-acetilkolin-receptor-agonisták alkalmazása nyugtalan láb szindróma kezelésére alkalmas gyógyszerkészítmények előállítására - Google Patents
Nikotinsav-acetilkolin-receptor-agonisták alkalmazása nyugtalan láb szindróma kezelésére alkalmas gyógyszerkészítmények előállításáraInfo
- Publication number
- HUP0401967A2 HUP0401967A2 HU0401967A HUP0401967A HUP0401967A2 HU P0401967 A2 HUP0401967 A2 HU P0401967A2 HU 0401967 A HU0401967 A HU 0401967A HU P0401967 A HUP0401967 A HU P0401967A HU P0401967 A2 HUP0401967 A2 HU P0401967A2
- Authority
- HU
- Hungary
- Prior art keywords
- treatment
- acetylcholine receptor
- restless legs
- legs syndrome
- preparation
- Prior art date
Links
- 208000005793 Restless legs syndrome Diseases 0.000 title abstract 4
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 title 1
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
- QFBCQOXKGBYUSU-UHFFFAOYSA-M 2-acetyloxyethyl(trimethyl)azanium;pyridine-3-carboxylate Chemical compound [O-]C(=O)C1=CC=CN=C1.CC(=O)OCC[N+](C)(C)C QFBCQOXKGBYUSU-UHFFFAOYSA-M 0.000 abstract 2
- 229940122578 Acetylcholine receptor agonist Drugs 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
A találmány tárgya eljárás nyugtalanláb szindrómától szenvedő alanykezelésére, amely szerint az ilyen kezelésre szoruló alanynak egynikotinsav-acetilkolin-receptor-agonistának a szindróma kezeléséhezhatásos mennyiségét adják be. A találmány tárgya továbbá nikotinsav-acetilkolin-receptor-agonista vegyület vagy annak gyógyászatilagelfogadható sója alkalmazása nyugtalanláb szindróma (RLS) kezeléséreszolgáló gyógyszer előállítására. Ó
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33481001P | 2001-10-31 | 2001-10-31 | |
| US33585801P | 2001-11-26 | 2001-11-26 | |
| PCT/IB2002/004379 WO2003037329A1 (en) | 2001-10-31 | 2002-10-21 | Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0401967A2 true HUP0401967A2 (hu) | 2005-01-28 |
Family
ID=26989404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0401967A HUP0401967A2 (hu) | 2001-10-31 | 2002-10-21 | Nikotinsav-acetilkolin-receptor-agonisták alkalmazása nyugtalan láb szindróma kezelésére alkalmas gyógyszerkészítmények előállítására |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1439836A1 (hu) |
| JP (1) | JP2005507411A (hu) |
| KR (1) | KR20050038583A (hu) |
| CN (1) | CN1568184A (hu) |
| BR (1) | BR0213696A (hu) |
| CA (1) | CA2460118A1 (hu) |
| CZ (1) | CZ2004524A3 (hu) |
| HU (1) | HUP0401967A2 (hu) |
| IL (1) | IL160967A0 (hu) |
| MX (1) | MXPA04002539A (hu) |
| PL (1) | PL370549A1 (hu) |
| SK (1) | SK1912004A3 (hu) |
| TW (1) | TW200300139A (hu) |
| WO (1) | WO2003037329A1 (hu) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006528237A (ja) * | 2003-05-20 | 2006-12-14 | ファイザー・プロダクツ・インク | バレニクリンの医薬組成物 |
| BRPI0414481A (pt) | 2003-09-17 | 2006-11-14 | Xenoport Inc | métodos de tratamento ou de prevenção da sìndrome das pernas inquietas em um paciente e de melhoria do sono em um paciente com sìndrome das pernas inquietas, e, composição farmacêutica |
| EA025871B9 (ru) | 2005-10-07 | 2017-08-31 | Экселиксис, Инк. | Ингибиторы mek и способы их применения |
| ES2703723T3 (es) | 2006-12-14 | 2019-03-12 | Exelixis Inc | Métodos para usar inhibidores de MEK |
| ES2880399T3 (es) | 2012-07-27 | 2021-11-24 | Neurodyn Life Sciences Inc | Biodisponibilidad cerebral mejorada de galantamina mediante formulaciones seleccionadas y administración transmucosa de profármacos lipofílicos |
| DK2877165T3 (da) * | 2012-07-27 | 2019-01-02 | Neurodyn Life Sciences Inc | Forbedret hjerne biotilgængelighed af galantamin ved udvalgte formuleringer og transmukosal administration af lipofil prodrug |
| KR102204520B1 (ko) | 2012-10-12 | 2021-01-20 | 엑셀리시스, 인코포레이티드 | 암의 치료에 사용하기 위한 화합물의 신규 제조 방법 |
| WO2016188932A2 (en) | 2015-05-22 | 2016-12-01 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Combination compositions and their use in methods for treating obesity and obesity-related disorders |
| WO2018236957A1 (en) * | 2017-06-20 | 2018-12-27 | Nexien Biopharma, Inc. | METHOD AND COMPOSITIONS FOR TREATING REST-FREE LEG SYNDROME |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6020335A (en) * | 1997-02-06 | 2000-02-01 | Pfizer Inc | (N-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents |
| US5977131A (en) * | 1997-04-09 | 1999-11-02 | Pfizer Inc. | Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents |
| US6605610B1 (en) * | 1997-12-31 | 2003-08-12 | Pfizer Inc | Aryl fused azapolycyclic compounds |
| EP0955301A3 (en) * | 1998-04-27 | 2001-04-18 | Pfizer Products Inc. | 7-aza-bicyclo[2.2.1]-heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylcholine receptors |
| PL344010A1 (en) * | 1998-04-29 | 2001-09-24 | Pfizer Prod Inc | Aryl fused azapolycyclic compounds |
-
2002
- 2002-10-21 HU HU0401967A patent/HUP0401967A2/hu unknown
- 2002-10-21 BR BR0213696-1A patent/BR0213696A/pt not_active IP Right Cessation
- 2002-10-21 SK SK191-2004A patent/SK1912004A3/sk not_active Application Discontinuation
- 2002-10-21 CA CA002460118A patent/CA2460118A1/en not_active Abandoned
- 2002-10-21 IL IL16096702A patent/IL160967A0/xx unknown
- 2002-10-21 JP JP2003539673A patent/JP2005507411A/ja active Pending
- 2002-10-21 PL PL02370549A patent/PL370549A1/xx not_active Application Discontinuation
- 2002-10-21 CN CNA028200292A patent/CN1568184A/zh active Pending
- 2002-10-21 EP EP02802239A patent/EP1439836A1/en not_active Withdrawn
- 2002-10-21 MX MXPA04002539A patent/MXPA04002539A/es unknown
- 2002-10-21 WO PCT/IB2002/004379 patent/WO2003037329A1/en not_active Application Discontinuation
- 2002-10-21 CZ CZ2004524A patent/CZ2004524A3/cs unknown
- 2002-10-21 KR KR1020047006544A patent/KR20050038583A/ko not_active Application Discontinuation
- 2002-10-30 TW TW091132199A patent/TW200300139A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL160967A0 (en) | 2004-08-31 |
| MXPA04002539A (es) | 2004-05-31 |
| PL370549A1 (en) | 2005-05-30 |
| KR20050038583A (ko) | 2005-04-27 |
| EP1439836A1 (en) | 2004-07-28 |
| WO2003037329A1 (en) | 2003-05-08 |
| TW200300139A (en) | 2003-05-16 |
| JP2005507411A (ja) | 2005-03-17 |
| CN1568184A (zh) | 2005-01-19 |
| CZ2004524A3 (cs) | 2004-07-14 |
| SK1912004A3 (en) | 2004-09-08 |
| BR0213696A (pt) | 2004-10-26 |
| CA2460118A1 (en) | 2003-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA86621C2 (ru) | Антагонисты рецептора глюкагона, их получение и терапевтическое применение | |
| PL1687305T3 (pl) | Pochodne 1H-imidazochinolin jako inhibitory kinaz białkowych | |
| NO20074567L (no) | Glucagonreseptorantagoniser, fremstilling og terapeutisk anvendelse | |
| EE04911B1 (et) | Ühend ja farmatseutiline kompositsioon proteaasi inhibiitoritena, nende kasutamine ning meetod selle ühendi valmistamiseks | |
| DK1957484T3 (da) | Glucagon-receptorantagonister, fremstilling og terapeutiske anvendelser | |
| MX2007008614A (es) | Peptidos con actividad agonista del receptor del neuropeptido-2 (y2r). | |
| UA83659C2 (ru) | Антагонисты рецепторов p2x7 и их применение, фармацевтическая композиция на их основе, способ их получения (варианты) | |
| JO2371B1 (en) | 4-phenyl-pyridine derivatives | |
| NO20044731L (no) | Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere | |
| NO20052739L (no) | CCR5-antagonister som medikamenter | |
| NO20061737L (no) | Aminosubstituerte erylamino B2 adrenergiske receptoragonister | |
| NO20043367L (no) | Oralt farmasoytisk preparat | |
| WO2006025070A3 (en) | Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol | |
| GEP20104962B (en) | Fused heterocyclic compounds | |
| WO2007120270A3 (en) | Glucagon receptor antagonists, preparation and therapeutic uses | |
| PH12014500937A1 (en) | 5-ht 1a receptor substype agonist | |
| ATE383850T1 (de) | Pulver enthaltend neuartige oligosaccharidgemische und verfahren zu deren herstellung | |
| MXPA04002338A (es) | Derivados de carbazol y su uso como antagonistas receptores del npy5. | |
| DK1951659T3 (da) | Glucagonreceptorantagonister, fremstilling og terapeutisk anvendelse heraf | |
| SE0102036D0 (sv) | Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof | |
| SG147450A1 (en) | Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof | |
| HUP0401967A2 (hu) | Nikotinsav-acetilkolin-receptor-agonisták alkalmazása nyugtalan láb szindróma kezelésére alkalmas gyógyszerkészítmények előállítására | |
| DK1057828T3 (da) | Orale trovafloxacin-suspensioner | |
| SE0102440D0 (sv) | New compound | |
| MXPA03010054A (es) | Composiciones que comprenden lopinavir y metodos para aumentar la biodisponibilidad de agentes farmaceuticos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |